Skip to main navigation Skip to search Skip to main content

Molecular immune pathogenesis and diagnosis of COVID-19

  • Xiaowei Li
  • , Manman Geng
  • , Yizhao Peng
  • , Liesu Meng
  • , Shemin Lu
  • Xi'an Jiaotong University
  • Key Lab of the Ministry of Education for Process Control and Efficiency Egineering

Research output: Contribution to journalReview articlepeer-review

1270 Scopus citations

Abstract

Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection.

Original languageEnglish
Pages (from-to)102-108
Number of pages7
JournalJournal of Pharmaceutical Analysis
Volume10
Issue number2
DOIs
StatePublished - Apr 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Coronavirus
  • MERS-CoV
  • Pathogenesis
  • SARS-CoV
  • SARS-CoV-2

Fingerprint

Dive into the research topics of 'Molecular immune pathogenesis and diagnosis of COVID-19'. Together they form a unique fingerprint.

Cite this